RPRX Buybacks
9 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–9; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Royalty Pharma plc | 2026-03-31 | Reported repurchase cash | $50.1M |
| Royalty Pharma plc | 2025-12-31 | Reported repurchase cash | $80.54M |
| Royalty Pharma plc | 2025-03-31 | Reported repurchase cash | $708.78M |
| Royalty Pharma plc | 2024-12-31 | Reported repurchase cash | $52.61M |
| Royalty Pharma plc | 2024-03-31 | Reported repurchase cash | $0.00 |
| Royalty Pharma plc | 2023-12-31 | Reported repurchase cash | $30.2M |
| Royalty Pharma plc | 2022-12-31 | Reported repurchase cash | $0.00 |
| Royalty Pharma plc | 2020-12-31 | Reported repurchase cash | $0.00 |
| Royalty Pharma plc | 2019-12-31 | Reported repurchase cash | $38,000.00 |